formaldehyde has been researched along with bisabolol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aktumsek, A; Amarante, RKL; Amarante, RS; Barreto, AS; Barreto, RSS; Coutinho, HDM; Duarte, MC; Menezes, IRA; Nascimento, TS; Pereira, EWM; Quintans, JSS; Quintans-Júnior, LJ; Zengin, G | 1 |
Campos, AR; da Costa, FN; de Vasconcellos Abdon, AP; Duailibe, MA; Melo, LT; Pessoa, LM; Vieira-Neto, AE | 1 |
2 other study(ies) available for formaldehyde and bisabolol
Article | Year |
---|---|
Evidence for the involvement of TNF-α and IL-1β in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-α-bisabolol, its main compound, in mice.
Topics: Analgesics; Animals; Anti-Infective Agents; Capsaicin; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Facial Pain; Flame Ionization; Formaldehyde; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Interleukin-1beta; Male; Mice; Monocyclic Sesquiterpenes; Nociception; Nociceptive Pain; Oils, Volatile; Phytotherapy; Plant Extracts; Plant Oils; Plants, Medicinal; Pleurisy; Sesquiterpenes; Stachys; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
(-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.
Topics: Acrolein; Administration, Oral; Administration, Topical; Analgesics; Animals; Behavior, Animal; Binding Sites; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Compounding; Facial Pain; Formaldehyde; Male; Mice; Molecular Docking Simulation; Monocyclic Sesquiterpenes; Nociception; Nociceptive Pain; Protein Binding; Protein Conformation; Rats, Wistar; Sesquiterpenes; Temporomandibular Joint; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPC Cation Channels | 2017 |